Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EC HealthcareHKSE:02138 +1.12%56 EV-to-FCF is 1.85 as of Aug. 10, 2026, which is 87% below its 10-year median of 13.73. GuruFocus rates HKSE:02138 with a GF Score™ of 56/100 and a GF Value™ of HK$0.72 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 405 Healthcare Providers & Services companies, EC Healthcare ranks better than 95.06% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, EC Healthcare's Enterprise Value is HK$1,124 Mil.
EC Healthcare's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was HK$607 Mil. Therefore, EC Healthcare's EV-to-FCF for today is 1.85.
The historical rank and industry rank for EC Healthcare's EV-to-FCF or its related term are showing as below:
HKSE:02138'
s EV-to-FCF Range Over the Past 10 Years
Min: -148.86 Med: 13.73 Max: 45.37
Current: 1.85
During the past 12 years, the highest EV-to-FCF of EC Healthcare was 45.37. The lowest was -148.86. And the median was 13.73.
HKSE:02138's EV-to-FCF is ranked better than 95.06% of 405
companies
in the Healthcare Providers & Services industry
Industry Median: 18.84
vs HKSE:02138: 1.85
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EC Healthcare's PE Ratio (TTM) for today is calculated as:
EC Healthcare's share price for today is HK$0.45.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. EC Healthcare's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was HK$-0.340.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
EC Healthcare EV-to-FCF Related Terms
EC Healthcare EV-to-FCF Historical Data
* Premium members only.
The historical data trend for EC Healthcare's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, EC Healthcare's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EC Healthcare EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, EC Healthcare's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where EC Healthcare's EV-to-FCF falls into.
EC Healthcare's current Enterprise Value is HK$1,124 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. EC Healthcare's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was HK$607 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EC Healthcare (HKSE:02138) has a EV-to-FCF of 1.85 as of Aug. 10, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on EC Healthcare and its competitors. This is 87% below median its historical median of 13.73. According to the industry distribution chart, EC Healthcare ranks #20 out of 405 companies in the Healthcare Providers & Services industry, placing it in the top 4.9%.
Is EC Healthcare's EV-to-FCF too high?
EC Healthcare's current EV-to-FCF of 1.85 is 87% below median its 10-year median of 13.73. The Healthcare Providers & Services industry median EV-to-FCF is 18.84. EC Healthcare's value of 1.85 is 90.2% below this industry median. Based on the distribution chart, EC Healthcare ranks #20 out of 405 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, EC Healthcare has a GF Score™ of 56/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does EC Healthcare's EV-to-FCF compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, EC Healthcare ranks #20 out of 405 companies for EV-to-FCF. This places EC Healthcare in the top 5% of its industry — outperforming the majority of peers. The industry median EV-to-FCF is 18.84. EC Healthcare's value of 1.85 is 90.2% below this benchmark. While the company's 10-year median is 13.73 vs. the industry median of 18.84, EC Healthcare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 18.84, based on 405 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. EC Healthcare's current EV-to-FCF of 1.85 is 90.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on EC Healthcare and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 18.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EC Healthcare's current EV-to-FCF is 1.85, which is 87% below median its own 10-year median of 13.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EC Healthcare stock overvalued right now?
Based on GuruFocus' analysis, EC Healthcare (HKSE:02138) is currently considered Possible Value Trap. The stock's GF Value™ is HK$0.72, compared to a current price of HK$0.45 — trading 37.5% below its estimated fair value. The current EV-to-FCF is 1.85, which is 87% below median its 10-year median of 13.73 and 90.2% below the Healthcare Providers & Services industry median of 18.84. EC Healthcare's overall GF Score™ is 56/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For EC Healthcare (HKSE:02138), the current EV-to-FCF is 1.85 as of Aug. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EC Healthcare (HKSE:02138) Overvalued in 2026?
Based on GuruFocus' analysis, EC Healthcare stock appears to be undervalued.
The current stock price of HK$0.45 is trading 37.5% below its estimated GF Value™ of HK$0.72.
GuruFocus considers EC Healthcare to be Possible Value Trap.
Key valuation signals for HKSE:02138:
EV-to-FCF: 1.85 (87% below median its 10-year median of 13.73)
GF Value™: HK$0.72 vs. price of HK$0.45 (37.5% below fair value)
Industry Position: 90.2% below the Healthcare Providers & Services median (#20 of 405)
No single metric tells the full story. See the HKSE:02138 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EC Healthcare is a Hong Kong-based non-hospital medical service provider. The principal activities of the group include the provision of medical services; aesthetic medical services, comprising medical aesthetics and dental services; beauty and wellness services, comprising traditional beauty, haircare, and ancillary wellness services; and the sale of skincare, healthcare, and beauty products. The group caters to its services through the operating segments of Medical, which is the key revenue generator segment and Aesthetic medical, beauty and wellness, Veterinary, and others. Geographically, the group has a business presence in Hong Kong, Macau, Mainland China, and Taiwan. It generates the majority of its revenue from Hong Kong.
56GF Score
Get the complete analysis for HKSE:02138
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02138 has been successfully added to your 
